The stock price of Navigation Pharmaceutical Biotechnology rose big pump 240%, related to the Conflux acquisition plan.

Gate News bot message, on July 2, the Hong Kong listed company Pioneer Pharma Biotech (00399) experienced unusual activity in the morning, with the stock price soaring to 0.7 HKD, a rise of nearly 240%. As of the time of writing, the stock price has retreated to around 0.34 HKD.

According to reports, Navigating Pharmaceutical Biotech previously announced plans to acquire all shares of Conflux to expand its blockchain business. It is worth noting that two founding members of Conflux are currently serving as executive directors of Navigating Pharmaceutical Biotech.

Source: PANews

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)